Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients.
Transl Oncol. 2016 Dec;9(6):505-511. doi: 10.1016/j.tranon.2016.09.003. Epub 2016 Oct 29.
Transl Oncol. 2016.
PMID: 27816687
Free PMC article.
18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non-Small Cell Lung Cancer Patients: A Comparison of Assessment Methods.
Fledelius J, Winther-Larsen A, Khalil AA, Bylov CM, Hjorthaug K, Bertelsen A, Frøkiær J, Meldgaard P.
Fledelius J, et al. Among authors: bylov cm.
J Nucl Med. 2017 Dec;58(12):1931-1937. doi: 10.2967/jnumed.117.193003. Epub 2017 May 10.
J Nucl Med. 2017.
PMID: 28490472
Free article.
Item in Clipboard
Cite
Cite